Susan Wilder
Family Medicine · Scottsdale, AZNPI 1447218698
Payments from drug & device makers
Across 173 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$573
- AstraZeneca$476
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$329
- Novo Nordisk$234
- Lilly USA, LLC$233
- Abbott$141
- plus $1K from 34 others
What the payments were for
- Food & beverage$3,288100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,288 in reported general payments places this provider in the 85th percentile of 2,099 family medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $37,093 |
| FarxigaDapagliflozin Propanediol | 23 | $19,814 |
| NexletolBempedoic Acid | 24 | $14,246 |
| JardianceEmpagliflozin | 23 | $13,851 |
| VeozahFezolinetant | 11 | $6,009 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,211 |
| Rosuvastatin Calcium | 143 | $2,177 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $1,851 |
| Levothyroxine Sodium | 122 | $1,662 |
| ValacyclovirValacyclovir Hcl | 36 | $1,537 |
| PaxlovidNirmatrelvir/Ritonavir | 33 | $1,429 |
| Estradiol (Twice Weekly)Estradiol | 14 | $1,295 |
| SynthroidLevothyroxine Sodium | 21 | $1,222 |
| Estradiol | 17 | $1,186 |
| Ezetimibe | 36 | $994 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $117 | $38,52264 claims |
| AstraZenecaFarxiga | $476 | $19,81423 claims |
| Esperion Therapeutics, Inc.Nexletol | $13 | $14,24624 claims |
| Astellas Pharma US IncVeozah | $64 | $6,00911 claims |
| GSKBreo Ellipta | $63 | $5,21112 claims |
| AbbVieSynthroid | $573 | $1,22221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Scottsdale
- Danielle ArmasScottsdale$73M
- Joseph LilloScottsdale$6.3M
- Sam FereidouniScottsdale$486K
- Casey MyersScottsdale$246K
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
- Corey AndersonMesa$21.5M
- Dena PetersenTucson$14.7M
- Gerald ShockeyMesa$12.3M
- Brock MerrittPhoenix$8.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.